Increased transparency was required when reporting imputation of primary outcome data in clinical trials.

Kearney, Anna; Rosala-Hallas, Anna; Rainford, Naomi; Blazeby, Jane M; Clarke, Mike; Lane, Athene J; Gamble, Carrol

Kearney, Anna; Rosala-Hallas, Anna; Rainford, Naomi; Blazeby, Jane M; Clarke, Mike; Lane, Athene J; Gamble, Carrol.

Afiliación

Kearney A; Department of Health Data Science, University of Liverpool, Liverpool, UK. Electronic address: a.kearney@liverpool.ac.uk.
Rosala-Hallas A; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
Rainford N; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
Blazeby JM; Bristol Biomedical Research Centre, Population health sciences, University of Bristol, Bristol, UK.
Clarke M; Northern Ireland Methodology Hub, Centre for Public Health, Queen's University Belfast, Belfast, UK.
Lane AJ; CONDuCTII Hub for Trials Methodology Research, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Gamble C; Department of Health Data Science, University of Liverpool, Liverpool, UK; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.

J Clin Epidemiol ; 146: 60-67, 2022 06.

Article en En | MEDLINE | ID: mdl-35218883

Asunto(s)

Publicaciones; Humanos; Ensayos Clínicos Controlados Aleatorios como Asunto

Palabras clave

CONSORT; Imputation; Missing data; Reporting transparency; Retention

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Publicaciones Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google